Related Experiment Video
Updated: Jun 18, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Moderate recurrent hypoglycemia during early development leads to persistent changes in affective behavior in the rat
Holly Moore1, Tara K S Craft, Lisa M Grimaldi
1Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. hm2035@columbia.edu
Insights
Recurrent juvenile hypoglycemia in rats led to lasting increases in fear and stress responses, impacting social behavior. These effects persisted into adulthood even after blood glucose normalized.
Area of Science:
- Neuroscience
- Developmental Psychology
- Endocrinology
Background:
- Recurrent hypoglycemia is common in children, linked to metabolic disorders and diabetes.
- Previous studies suggest a link between juvenile hypoglycemia and psychological issues.
- Direct effects of recurrent moderate hypoglycemia on development are not fully understood.
Purpose of the Study:
- To investigate the long-term effects of recurrent juvenile hypoglycemia on affective, social, and motor functions in an animal model.
- To determine if these effects persist into adulthood under normal blood glucose conditions.
Main Methods:
- Rats received insulin or saline injections twice daily from postnatal day 10 to 19 to model recurrent hypoglycemia.
- Behavioral tests assessed affective reactivity, stress responses, and social play.
- Effects were evaluated across development, including infancy, juvenility, and early adulthood.
Main Results:
- Insulin-treated rats showed stunted weight gain during treatment, which later recovered.
- Increased affective reactivity (vocalizations, startle reflex) emerged early and persisted.
- Adult rats exhibited heightened fear responses and stress reactivity, with some sex-dependent effects.
- Social play behavior in adolescents was reduced.
Conclusions:
- Recurrent juvenile hypoglycemia can cause persistent increases in fear-related behaviors and stress reactivity.
- These neurodevelopmental changes are not reversed by normalizing blood glucose levels.
- Findings highlight potential long-term psychological consequences of early-life hypoglycemia.
Abstract:
Recurrent hypoglycemia is a common problem among infants and children that is associated with several metabolic disorders and insulin-dependent diabetes mellitus. Although studies have reported a relationship between a history of juvenile hypoglycemia and psychological health problems, the direct effects of recurrent moderate hypoglycemia have not been fully determined. Thus, in this study, we used an animal model to examine the effects of recurrent hypoglycemia during the juvenile period on affective, social, and motor function (assessed under euglycemic conditions) across development. To model recurrent hypoglycemia, rats were administered 5 U/kg of insulin or saline twice per day from postnatal day (P)10 to P19. Body weight gain was retarded in insulin-treated rats during the treatment period, but recovered by the end of treatment. However, insulin-treated rats displayed increases in affective reactivity that emerged early during treatment and persisted after treatment into early adulthood. Specifically, insulin-treated pups showed increased maternal separation-induced vocalizations as infants, and an exaggerated acoustic startle reflex as juveniles and young adults. Moreover, young adult rats with a history of recurrent juvenile hypoglycemia exhibited increased fear-potentiated startle and increases in behavioral and hormonal responses to restraint stress. Some of these effects were sex-dependent. The changes in affective behavior in insulin-exposed pups were accompanied by decreases in adolescent social play behavior. These results provide evidence that recurrent, transient hypoglycemia during juvenile development can lead to increases in fear-related behavior and stress reactivity. Importantly, these phenotypes are not reversed with normalization of blood glucose and may persist into adulthood.
Related Concept Videos
Hypoglycemia and Glucagon
Hypoglycemia
Type II Diabetes II: Pathophysiology
